Cargando…
The Role of Metabolic Dysfunction–Associated Fatty Liver Disease in Developing Chronic Kidney Disease: Longitudinal Cohort Study
BACKGROUND: The association between metabolic dysfunction–associated fatty liver disease (MAFLD) and chronic kidney disease (CKD) is unclear. OBJECTIVE: This longitudinal cohort study aimed to test whether MAFLD plays an important role in the development of CKD. METHODS: This cohort study included 4...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
JMIR Publications
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10196898/ https://www.ncbi.nlm.nih.gov/pubmed/37140958 http://dx.doi.org/10.2196/45050 |
_version_ | 1785044443460534272 |
---|---|
author | Wei, Suosu Song, Jian Xie, Yujie Huang, Junzhang Yang, Jianrong |
author_facet | Wei, Suosu Song, Jian Xie, Yujie Huang, Junzhang Yang, Jianrong |
author_sort | Wei, Suosu |
collection | PubMed |
description | BACKGROUND: The association between metabolic dysfunction–associated fatty liver disease (MAFLD) and chronic kidney disease (CKD) is unclear. OBJECTIVE: This longitudinal cohort study aimed to test whether MAFLD plays an important role in the development of CKD. METHODS: This cohort study included 41,246 participants who had undergone 3 or more health examinations from 2008 to 2015 at the People’s Hospital of Guangxi Zhuang Autonomous Region, China. Participants were categorized into 2 groups according to whether they presented with or without MAFLD. The occurrence of new-onset CKD was stated as either an estimated glomerular filtration rate of <60 mL/min per 1.73 m(2) or a higher level of albuminuria during their follow-up appointment. The association between MAFLD and CKD was evaluated using a Cox regression method. RESULTS: Of the 41,246 participants, 11,860 (28.8%) were diagnosed with MAFLD. Over the course of the 14-year follow-up (median 10.0 years), 5347 (13%) participants experienced a new incident of CKD (135.73 per 10,000 person-years). MAFLD was discovered as an important risk factor for new incidents of CKD (hazard ratio 1.18, 95% CI 1.11-1.26) by using the multivariable Cox proportional hazard regression model. When stratified by gender, the adjusted hazard ratio for the incidence of CKD in men and women with MAFLD were 1.16 (95% CI 1.07-1.26) and 1.32 (95% CI 1.18-1.48), respectively. According to the subgroup analysis results, after adjusting for confounding factors, the MAFLD-related CKD risk was greater in men aged <60 years (P(interaction)=.001) and in those with combined dyslipidemia (P(interaction)=.02), but this relationship was not found in women (all P(interaction)>.05). CONCLUSIONS: MAFLD plays an important role in the development of new incidents of CKD in the long run. TRIAL REGISTRATION: Chinese Clinical Trial Registry ChiCTR2200058543; https://www.chictr.org.cn/showproj.html?proj=153109 |
format | Online Article Text |
id | pubmed-10196898 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | JMIR Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-101968982023-05-20 The Role of Metabolic Dysfunction–Associated Fatty Liver Disease in Developing Chronic Kidney Disease: Longitudinal Cohort Study Wei, Suosu Song, Jian Xie, Yujie Huang, Junzhang Yang, Jianrong JMIR Public Health Surveill Original Paper BACKGROUND: The association between metabolic dysfunction–associated fatty liver disease (MAFLD) and chronic kidney disease (CKD) is unclear. OBJECTIVE: This longitudinal cohort study aimed to test whether MAFLD plays an important role in the development of CKD. METHODS: This cohort study included 41,246 participants who had undergone 3 or more health examinations from 2008 to 2015 at the People’s Hospital of Guangxi Zhuang Autonomous Region, China. Participants were categorized into 2 groups according to whether they presented with or without MAFLD. The occurrence of new-onset CKD was stated as either an estimated glomerular filtration rate of <60 mL/min per 1.73 m(2) or a higher level of albuminuria during their follow-up appointment. The association between MAFLD and CKD was evaluated using a Cox regression method. RESULTS: Of the 41,246 participants, 11,860 (28.8%) were diagnosed with MAFLD. Over the course of the 14-year follow-up (median 10.0 years), 5347 (13%) participants experienced a new incident of CKD (135.73 per 10,000 person-years). MAFLD was discovered as an important risk factor for new incidents of CKD (hazard ratio 1.18, 95% CI 1.11-1.26) by using the multivariable Cox proportional hazard regression model. When stratified by gender, the adjusted hazard ratio for the incidence of CKD in men and women with MAFLD were 1.16 (95% CI 1.07-1.26) and 1.32 (95% CI 1.18-1.48), respectively. According to the subgroup analysis results, after adjusting for confounding factors, the MAFLD-related CKD risk was greater in men aged <60 years (P(interaction)=.001) and in those with combined dyslipidemia (P(interaction)=.02), but this relationship was not found in women (all P(interaction)>.05). CONCLUSIONS: MAFLD plays an important role in the development of new incidents of CKD in the long run. TRIAL REGISTRATION: Chinese Clinical Trial Registry ChiCTR2200058543; https://www.chictr.org.cn/showproj.html?proj=153109 JMIR Publications 2023-05-04 /pmc/articles/PMC10196898/ /pubmed/37140958 http://dx.doi.org/10.2196/45050 Text en ©Suosu Wei, Jian Song, Yujie Xie, Junzhang Huang, Jianrong Yang. Originally published in JMIR Public Health and Surveillance (https://publichealth.jmir.org), 04.05.2023. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, first published in JMIR Public Health and Surveillance, is properly cited. The complete bibliographic information, a link to the original publication on https://publichealth.jmir.org, as well as this copyright and license information must be included. |
spellingShingle | Original Paper Wei, Suosu Song, Jian Xie, Yujie Huang, Junzhang Yang, Jianrong The Role of Metabolic Dysfunction–Associated Fatty Liver Disease in Developing Chronic Kidney Disease: Longitudinal Cohort Study |
title | The Role of Metabolic Dysfunction–Associated Fatty Liver Disease in Developing Chronic Kidney Disease: Longitudinal Cohort Study |
title_full | The Role of Metabolic Dysfunction–Associated Fatty Liver Disease in Developing Chronic Kidney Disease: Longitudinal Cohort Study |
title_fullStr | The Role of Metabolic Dysfunction–Associated Fatty Liver Disease in Developing Chronic Kidney Disease: Longitudinal Cohort Study |
title_full_unstemmed | The Role of Metabolic Dysfunction–Associated Fatty Liver Disease in Developing Chronic Kidney Disease: Longitudinal Cohort Study |
title_short | The Role of Metabolic Dysfunction–Associated Fatty Liver Disease in Developing Chronic Kidney Disease: Longitudinal Cohort Study |
title_sort | role of metabolic dysfunction–associated fatty liver disease in developing chronic kidney disease: longitudinal cohort study |
topic | Original Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10196898/ https://www.ncbi.nlm.nih.gov/pubmed/37140958 http://dx.doi.org/10.2196/45050 |
work_keys_str_mv | AT weisuosu theroleofmetabolicdysfunctionassociatedfattyliverdiseaseindevelopingchronickidneydiseaselongitudinalcohortstudy AT songjian theroleofmetabolicdysfunctionassociatedfattyliverdiseaseindevelopingchronickidneydiseaselongitudinalcohortstudy AT xieyujie theroleofmetabolicdysfunctionassociatedfattyliverdiseaseindevelopingchronickidneydiseaselongitudinalcohortstudy AT huangjunzhang theroleofmetabolicdysfunctionassociatedfattyliverdiseaseindevelopingchronickidneydiseaselongitudinalcohortstudy AT yangjianrong theroleofmetabolicdysfunctionassociatedfattyliverdiseaseindevelopingchronickidneydiseaselongitudinalcohortstudy AT weisuosu roleofmetabolicdysfunctionassociatedfattyliverdiseaseindevelopingchronickidneydiseaselongitudinalcohortstudy AT songjian roleofmetabolicdysfunctionassociatedfattyliverdiseaseindevelopingchronickidneydiseaselongitudinalcohortstudy AT xieyujie roleofmetabolicdysfunctionassociatedfattyliverdiseaseindevelopingchronickidneydiseaselongitudinalcohortstudy AT huangjunzhang roleofmetabolicdysfunctionassociatedfattyliverdiseaseindevelopingchronickidneydiseaselongitudinalcohortstudy AT yangjianrong roleofmetabolicdysfunctionassociatedfattyliverdiseaseindevelopingchronickidneydiseaselongitudinalcohortstudy |